Global Breast Biopsy Market Research Report

1. Global Breast Biopsy Market Trends – Forecasts to 2026 As per the GME report on the Breast Biopsy Market, it is estimated that the market is expected to show significant growth at a CAGR of 8.5% during the 2020-2026 period. Therising incidence of breast cancer percentage and growing demand for minimally invasive procedures is building the demand for the breast biopsy market. New product launch and rising breast cancer screening programs is triggering the demand of breast biopsy market. Technical advancements and an increase in the expenditure of companies towards breast cancer research studies are driving the growth of the market. However high cost involved in the procedure and associated side effects of the treatment is the major concern growing as a restraint factor for the breast biopsy market. Browse 157 Market Data Tables and 111 Figures spread through 183 Pages on "Global Breast Biopsy Market- Forecasts to 2026" https://www.globalmarketestimates.com/market- report/global-breast-biopsy-market-2504 By Product (Liquid Biopsy Instruments, Assay Kits, Localized Wires, Biopsy Tables, Guidance System, Biopsy Needles, and Others); By Type (Circulating Tumor DNA(Cdna), Circulating Tumor Cells, Liquid Breast Biopsy, Incisional, Excisional, Open Surgical Breast Biopsy, Vacuum Assisted Biopsy(VAB), Fine Needle Aspiration Biopsy(FNAB), Core Needle Biopsy (CNB), Needle Breast Biopsy, and Others); By Guidance (Microarray-based Biopsy, PCR-based Biopsy, NGS-based Biopsy, Liquid Biopsy, MRI- Guided Biopsy, Ultrasound Guided Biopsy, Mammography-guided Stereotactic Biopsy, Image-Guided Biopsy, and Other Guidance Technique); By Application (Recurrence Monitoring, Treatment Monitoring, Therapy Selection, and Early Cancer Screening); By Region (North America, Europe, Asia Pacific, MEA, and CSA); By Region (North America, Europe, Asia Pacific, MEA, and CSA), Company Market Share & Competitor Analysis Key Market Insights: The Global Breast Biopsy Marketis expected grow with a CAGR value of 8.5% during 2020- 2026 The biopsy needles are expected to dominate the breast biopsy market in the forecast period. Image-guided biopsy has evolved as the fastest-growing get of the market as the procedure is minimally invasive and shows excellent accuracy as open surgical biopsies. Early cancer screening is the dominating among all the applications. The reason behind the significant growth of the segment is the increasing prevalence of breast cancer, growing awareness among customers about early detection of the cancer. APAC is the highest growing region of the breast biopsy market and is expected to maintain the market growth momentum in the projected period as well. Key global players in the Global Breast Biopsy MarketincludeExact Sciences Corporation, Hologic, Inc., and Becton, Dickinson and Company, QIAGEN, Illumina, Inc., Danaher Corporation, Medtronic, IZI Medical Product, Argon Medical, STERYLAB S.r.l., Scion, LLC, Biocept Inc., Bio-Rad Laboratories, Inc., Medical Technologies, F. Hoffmann-La Roche Ltd, Menarini Silicon Biosystems, Spa, and Thermo Fisher Scientific, Inc., among others. Browse https://www.globalmarketestimates.com/market-report/global-breast-biopsy-market-2504 the Global Breast Biopsy MarketReport @:

2. Product Outlook (Revenue, USD Billion, 2020 - 2026) Liquid Biopsy Instruments Assay Kits Localized Wires Biopsy Tables Guidance System Biopsy Needles Others TypeOutlook (Revenue, USD Billion, 2020 - 2026) Circulating Tumor DNA(Cdna), Circulating Tumor Cells Liquid Breast Biopsy Incisional, Excisional Open Surgical Breast Biopsy Vacuum Assisted Biopsy(VAB) Fine Needle Aspiration Biopsy(FNAB) Core Needle Biopsy (CNB) Needle Breast Biopsy Others Guidance Type Outlook (Revenue, USD Billion, 2020 - 2026) Microarray-based Biopsy PCR-based Biopsy NGS-based Biopsy Liquid Biopsy MRI-Guided Biopsy Ultrasound Guided Biopsy Mammography-guided Stereotactic Biopsy Image-Guided Biopsy  Other Guidance Technique Application Outlook (Revenue, USD Billion, 2020 - 2026) Recurrence Monitoring Treatment Monitoring Therapy Selection Early Cancer Screening Regional Outlook (Revenue, USD Billion, 2020 - 2026) North America U.S. Canada Mexico Europe Germany

3. UK France Spain Italy Rest of Europe Asia Pacific China India Japan South Korea Australia Rest of APAC Central & South America Brazil Argentina Chile Rest of CSA Middle East & Africa Saudi Arabia South Africa UAE Rest of MEA Contact: Yash Jain Email address: sales@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php